NCT02387580View on ClinicalTrials.gov

Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Malaria

Interventions

DRUG

OZ439 + TPGS

DRUG

OZ439 Prototype 1

DRUG

OZ439 Prototype 3

DRUG

PQP

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors

Collaborators (1)

Quotient Clinical

All Listed Sponsors

collaborator

Quotient Clinical

OTHER

lead

Medicines for Malaria Venture

OTHER

NCT02387580 - Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets | Biotech Hunter | Biotech Hunter